Literature DB >> 19089472

Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K).

Julien Cassereau1, Arnaud Chevrollier, Naïg Gueguen, Marie-Claire Malinge, Franck Letournel, Guillaume Nicolas, Laurence Richard, Marc Ferre, Christophe Verny, Frédéric Dubas, Vincent Procaccio, Patrizia Amati-Bonneau, Dominique Bonneau, Pascal Reynier.   

Abstract

Mutations in GDAP1, an outer mitochondrial membrane protein responsible for recessive Charcot-Marie-Tooth disease (CMT4A), have also been associated with CMT2K, a dominant form of the disease. The three CMT2K patients we studied carried a novel dominant GDAP1 mutation, C240Y (c.719G > A). Mitochondrial respiratory chain complex I activity in fibroblasts from CMT2K patients was 40% lower than in controls, whereas the tubular mitochondria were 33% larger in diameter and the mitochondrial mass was 20% greater. Thus, besides the regulatory role GDAP1 plays in mitochondrial network dynamics, it may also be involved in energy production and in the control of mitochondrial volume.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19089472     DOI: 10.1007/s10048-008-0166-9

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  19 in total

1.  Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect.

Authors:  R Claramunt; L Pedrola; T Sevilla; A López de Munain; J Berciano; A Cuesta; B Sánchez-Navarro; J M Millán; G M Saifi; J R Lupski; J J Vílchez; C Espinós; F Palau
Journal:  J Med Genet       Date:  2005-04       Impact factor: 6.318

2.  Case records of the Massachusetts General Hospital. Case 18-2006. A 57-year-old woman with numbness and weakness of the feet and legs.

Authors:  William J Triggs; Robert H Brown; Daniel L Menkes
Journal:  N Engl J Med       Date:  2006-06-15       Impact factor: 91.245

Review 3.  Regulation of mitochondrial matrix volume.

Authors:  Allen Kaasik; Dzhamilja Safiulina; Alexander Zharkovsky; Vladimir Veksler
Journal:  Am J Physiol Cell Physiol       Date:  2006-07-26       Impact factor: 4.249

4.  Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins.

Authors:  Frédéric Legros; Anne Lombès; Paule Frachon; Manuel Rojo
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

Review 5.  Molecular cell biology of Charcot-Marie-Tooth disease.

Authors:  Philipp Berger; Peter Young; Ueli Suter
Journal:  Neurogenetics       Date:  2002-03       Impact factor: 2.660

6.  The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease.

Authors:  Ana Cuesta; Laia Pedrola; Teresa Sevilla; Javier García-Planells; María José Chumillas; Fernando Mayordomo; Eric LeGuern; Ignacio Marín; Juan J Vílchez; Francesc Palau
Journal:  Nat Genet       Date:  2001-12-17       Impact factor: 38.330

7.  Functional characterisation of ganglioside-induced differentiation-associated protein 1 as a glutathione transferase.

Authors:  Alison J Shield; Tracy P Murray; Philip G Board
Journal:  Biochem Biophys Res Commun       Date:  2006-07-20       Impact factor: 3.575

8.  Evolutionary and structural analyses of GDAP1, involved in Charcot-Marie-Tooth disease, characterize a novel class of glutathione transferase-related genes.

Authors:  Antonio Marco; Ana Cuesta; Laia Pedrola; Francesc Palau; Ignacio Marín
Journal:  Mol Biol Evol       Date:  2003-10-31       Impact factor: 16.240

9.  Hereditary optic neuropathies share a common mitochondrial coupling defect.

Authors:  Arnaud Chevrollier; Virginie Guillet; Dominique Loiseau; Naïg Gueguen; Marie-Anne Pou de Crescenzo; Christophe Verny; Marc Ferre; Hélène Dollfus; Sylvie Odent; Dan Milea; Cyril Goizet; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Pascal Reynier
Journal:  Ann Neurol       Date:  2008-06       Impact factor: 10.422

10.  Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease.

Authors:  Axel Niemann; Marcel Ruegg; Veronica La Padula; Angelo Schenone; Ueli Suter
Journal:  J Cell Biol       Date:  2005-09-19       Impact factor: 10.539

View more
  20 in total

1.  Whole genome expression profile in neuroblastoma cells exposed to 1-methyl-4-phenylpyridine.

Authors:  E Mazzio; K F A Soliman
Journal:  Neurotoxicology       Date:  2012-07-07       Impact factor: 4.294

Review 2.  Axon Transport and Neuropathy: Relevant Perspectives on the Etiopathogenesis of Familial Dysautonomia.

Authors:  Warren G Tourtellotte
Journal:  Am J Pathol       Date:  2015-12-24       Impact factor: 4.307

3.  A nonsense mutation in DHTKD1 causes Charcot-Marie-Tooth disease type 2 in a large Chinese pedigree.

Authors:  Wang-Yang Xu; Ming-Min Gu; Lian-Hua Sun; Wen-Ting Guo; Hou-Bao Zhu; Jian-Fang Ma; Wen-Tao Yuan; Ying Kuang; Bao-Jun Ji; Xiao-Lin Wu; Yan Chen; Hong-Xin Zhang; Fu-Ting Sun; Wei Huang; Lei Huang; Sheng-di Chen; Zhu-Gang Wang
Journal:  Am J Hum Genet       Date:  2012-11-08       Impact factor: 11.025

4.  [Analysis of GDAP1 gene mutation in a pedigree with autosomal dominant Charcot-Marie-Tooth disease].

Authors:  Li Qin; Canhong Yang; Tianming Lü; Lanying Li; Dandan Zong; Yueying Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-01-30

5.  L239F founder mutation in GDAP1 is associated with a mild Charcot-Marie-Tooth type 4C4 (CMT4C4) phenotype.

Authors:  Dagmara Kabzińska; Halina Strugalska-Cynowska; Anna Kostera-Pruszczyk; Barbara Ryniewicz; Renata Posmyk; Alina Midro; Pavel Seeman; Lucia Báranková; Magdalena Zimoń; Jonathan Baets; Vincent Timmerman; Velina Guergueltcheva; Ivailo Tournev; Stayko Sarafov; Peter De Jonghe; Albena Jordanova; Irena Hausmanowa-Petrusewicz; Andrzej Kochański
Journal:  Neurogenetics       Date:  2010-03-16       Impact factor: 2.660

Review 6.  Intermediate Charcot-Marie-Tooth disease.

Authors:  Lei Liu; Ruxu Zhang
Journal:  Neurosci Bull       Date:  2014-10-17       Impact factor: 5.203

7.  Dominant GDAP1 founder mutation is a common cause of axonal Charcot-Marie-Tooth disease in Finland.

Authors:  Mari Auranen; Emil Ylikallio; Jussi Toppila; Mirja Somer; Sari Kiuru-Enari; Henna Tyynismaa
Journal:  Neurogenetics       Date:  2013-03-03       Impact factor: 2.660

8.  Genotype-phenotype correlation and frequency of distribution in a cohort of Chinese Charcot-Marie-Tooth patients associated with GDAP1 mutations.

Authors:  Pukar Singh Pakhrin; Yongzhi Xie; Zhengmao Hu; Xiaobo Li; Lei Liu; Shunxiang Huang; Binghao Wang; Zihan Yang; Jiejun Zhang; Xin Liu; Kun Xia; Beisha Tang; Ruxu Zhang
Journal:  J Neurol       Date:  2018-01-25       Impact factor: 4.849

9.  Novel GDAP1 mutation in a Turkish family with CMT2K (CMT2K with novel GDAP1 mutation).

Authors:  Nilufer Sahin-Calapoglu; Meliha Tan; Mustafa Soyoz; Mustafa Calapoglu; Nurten Ozcelik
Journal:  Neuromolecular Med       Date:  2009-04-19       Impact factor: 3.843

10.  Identification of novel pathogenic copy number variations in Charcot-Marie-Tooth disease.

Authors:  J Mortreux; J Bacquet; A Boyer; E Alazard; R Bellance; A G Giguet-Valard; M Cerino; M Krahn; F Audic; B Chabrol; V Laugel; J P Desvignes; C Béroud; K Nguyen; A Verschueren; N Lévy; S Attarian; V Delague; C Missirian; N Bonello-Palot
Journal:  J Hum Genet       Date:  2019-12-18       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.